La vendita allo scoperto per Guardion Health Sciences dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Guardion Health Sciences. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Guardion Health Sciences (OTC:GHSI) Azioni, Report sulle vendite allo scoperto

Guardion Health Sciences

Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.

Guardion Health Sciences Inc

<a href="https://www.wsj.com/articles/hong-kong-is-becoming-hub-for-financial-crime-u-s-lawmakers-say-39043e46" title="https://www.wsj.com/articles/hong-kong-is-becoming-hub-for-financial-crime-u-s-lawmakers-say-39043e46">https://www.wsj.com/articles/hong-kong-is-becoming-hub-for-financial-crime-u-s-lawmakers-say-39043e46</a>

News

Legal

Wall Street Journal Reports U.S. House Committee Leaders Urge Rethink Of Banking Ties With Hong Kong, Citing Money-Laundering And Sanctions Evasion

Shares of Uxin Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NYSE">UXIN</a>) rose sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/quote/UXIN/earnings">second-quarter financial results.</a>
Uxin posted quarterly sales of $70.85 million, up from $48.80 million in the year-ago period
Uxin shares rose 3% to $6.50 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) gained 59.2% to $2.77 in pre-market trading after climbing around 18% on Friday.</li>
<li>Quantum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) rose 40.4% to $12.84 in pre-market trading after jumping 127% on Friday.</li>
<li>KULR Technology Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) gained 29.8% to $0.5777 in pre-market trading after gaining around 7% on Friday.</li>
<li>Exicure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) gained 28.4% to $23.59 in pre-market trading after jumping around 69% on Friday.</li>
<li>Arqit Quantum Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) gained 22% to $15.76 in pre-market trading after gaining 21% on Friday.</li>
<li>NOVONIX Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVX#NASDAQ">NVX</a>) gained 19.1% to $2.31 in pre-market trading. Novonix secured a 32,000-tonne offtake agreement with Volkswagen&#8217;s PowerCo for synthetic graphite supply.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) gained 16.9% to $7.13 in pre-market trading after jumping 28% on Friday.  </li>
<li>Allot Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLT#NASDAQ">ALLT</a>) climbed 16.7% to $4.94 in pre-market trading. Allot, last week, reported better-than-expected quarterly financial results.</li>
<li>Lionsgate Studios Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) gained 11.2% to $7.89 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Akoustis Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) shares tumbled 37.5% to $0.0629 in pre-market trading</li>
<li>Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) shares fell 17.8% to $0.1560 in pre-market trading. Aptose Biosciences shares dipped 22% on Friday after the company announced the pricing of an $8 million public offering.</li>
<li>X3 Holdings Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) declined 16.6% to $1.76 in pre-market trading.</li>
<li>NewGenIvf Group Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) fell 16.1% to $0.43 in pre-market trading after declining 6% on Friday.</li>
<li>Elevai Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) fell 13.9% to $0.0173 in pre-market trading. Elevai Labs implemented a 1-for-200 reverse stock split to retain Nasdaq listing, reducing shares to 3.07 million.</li>
<li>Gold Resource Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GORO#NYSE">GORO</a>) shares fell 13.1% to $0.1368 in pre-market trading after gaining 6% on Friday.</li>
<li>Digital Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) dipped 12.4% to $0.1063 in pre-market trading after falling over 4% on Friday.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) shares dipped 6.9% to $22.15 in pre-market trading. ZIM Integrated Shipping Services, last week, reported better-than-expected third-quarter financial results and raised its FY24 adjusted EBIT and EBITDA guidance.</li>
<li>ChromaDex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) fell 5.9% to $7.00 in pre-market trading.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) fell 4.3% to $6.90 in today's pre-market trading after jumping around 25% on Friday. Kingsoft Cloud, last week, reported a fiscal third-quarter 2024 revenue of 1.89 billion Chinese yuan ($268.7 million), up by 16.0% year-on-year, beating the analyst consensus estimate of $247.46 million</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

AKTS

ALLT

APTO

ARQQ

CDXC

DBGI

ELAB

GORO

KULR

LION

NIVF

Nuveen California Dividend Advantage Municipal Fund 2

QMCO

QUBT

RGTI

UXIN

XCUR

XTKG

Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Exane BNP Paribas analyst Kevin Grundy initiates coverage on Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Neutral rating and announces Price Target of $261.

Price Target

Initiation

Analyst Ratings

Exane BNP Paribas Initiates Coverage On Constellation Brands with Neutral Rating, Announces Price Target of $261

Donald Trump&#8217;s <a href="https://www.benzinga.com/general/market-summary/24/11/41968003/gold-drops-to-a-two-month-low-as-investors-turn-to-bitcoin-after-trumps-victory-but-this-economist-remains-confident-that-gold-will-surge">win is positive for the financial and energy sectors</a> as the &#8220;pro-growth effects of fiscal stimulus currently outweigh the inflationary risks in the near term​​​&#8221; according to an analyst. 
What Happened: Mario Georgiou, CFA and executive director, head of investments at InCred Global Wealth U.K., in an exclusive conversation with <a href="http://pro.benzinga.com">Benzinga</a>, described tax cuts and deregulation as tailwinds to the markets. He considers inflationary policies such as tariffs and immigration impacts as headwinds, leading to a steepening yield curve, and higher term premiums.
&#8220;Financials offer an attractive risk-reward and that this recent post-election rally has room to run,&#8221; added Georgiou. According to him &#8220;financials are not only well positioned to capture the benefits of the above-mentioned Trump tailwinds, but are also less impacted / would even benefit from the Trump headwinds.&#8221;
Despite a few dips, the equity markets have been trading higher than the pre-election levels after President-elect Trump&#8217;s victory. The S&amp;P 500 has increased by 3.22%, rising from $5,782.76 on Nov. 5 to $5,969.34 as of Friday&#8217;s close. The SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) which tracks the S&amp;P 500 Index has had a similar momentum, according to data from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Meanwhile, Financial Select Sector SPDR Fund (ACRA: XLF), Vanguard Financials ETF (ACRA: VFH), iShares U.S. Financials ETF (ACRA: IYF), and SPDR S&amp;P Bank ETF (ACRA: KBE), have returned over 30% year-to-date in 2024 outperforming the S&amp;P 500 Index&#8217;s 26% run.
Also read: <a href="https://www.benzinga.com/24/11/42131911/donald-trump-appointed-doge-to-have-marginal-impact-saving-50-100-billion-says-analyst-as-elon-musk-aims-to-target-500-billion-plus-in-federal-expenditures">Donald Trump&#8217;s DOGE Initiative To Have &#8216;Marginal Impact&#8217; Says Analyst As Elon Musk Aims To Target Over $500B In Federal Expenditures</a>
Other sectors that Georgiou prefers, include energy. According to him &#8220;deregulation supporting oil production and geopolitical risks could sustain elevated oil prices and relative valuations are attractive.&#8221;
Even though the energy sector has underperformed the broader markets in 2024, &#8220;fundamentally, companies are shareholder friendly with 8-12% shareholder yields, have strong balance sheets with low net debt to EBITDA ratios and high free cash flow yields of 6.50% and above,&#8221; he adds.
Invesco S&amp;P 500 Equal Weight ETF (ACRA: RSP), iShares Russell 1000 Value ETF (ACRA: IWD), Vanguard High Dividend Yield Index ETF (ACRA: VYM) and ProShares S&amp;P 500 Ex-Energy ETF (ACRA: SPXE) have all underperformed the S&amp;P 500 on a year-to-date basis.
Why It Matters: As markets hit their 51st record high of 2024 and the S&amp;P 500 Index crossed 6,000 points, some analysts caution that<a href="https://www.benzinga.com/24/11/42134031/markets-got-it-wrong-after-elections-prospects-of-tariffs-not-good-for-equities-vs-dollar-says-ex-goldman-sachs-analyst"> tariffs could pose risks </a>to equities and suggest that the market may be overvalued.
&#8220;The prospect of tariffs isn't obviously good for equities, while it's clearly good for the Dollar," former Goldman Sachs FX strategist and senior fellow at Brookings Institution, Robin Brooks said in an X post. "Markets initially got this wrong, driving stocks up sharply right after Nov. 5,&#8221; he added.
However, Georgiou is &#8220;cautiously optimistic&#8221; about the markets, he said &#8220;a neutral to fully invested equity allocation is warranted, with a focus on sectors benefiting from Trump's policies, whilst always maintaining our core investment principles, which is a focus on fundamentals, quality, and risk management.&#8221;
<ul>
<li>Read next: <a href="https://www.benzinga.com/24/11/42134031/markets-got-it-wrong-after-elections-prospects-of-tariffs-not-good-for-equities-vs-dollar-says-ex-goldman-sachs-analyst">Markets Misread Trump Win, Says Ex-Goldman Sachs Analyst: &#8216;Prospects Of Tariffs Not Good For Equities&#8217;</a></li>
</ul>
Image via Flickr

Equities

General

iShares Dow Jones US Financial Sector Index Fund

Rydex ETF Trust Rydex S&P Equal Weight ETF

SPXE

Donald Trump's Win Positive For Financials, Energy Sector As 'Pro-Growth Effects Will Outweigh Inflationary Pressures,' Says Analyst

Exane BNP Paribas analyst Kevin Grundy initiates coverage on Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) with a Neutral rating and announces Price Target of $64.

Exane BNP Paribas Initiates Coverage On Molson Coors Beverage with Neutral Rating, Announces Price Target of $64

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) CEO Tim Cook's approach to building a relationship with Donald Trump during his presidency reportedly gave Cupertino unique advantages over competitors. Other tech leaders may now be taking notes.
What Happened: A <a href="https://www.wsj.com/politics/elections/tim-cook-ceo-trump-relationship-ad106f36">report</a> by The Wall Street Journal highlights how Cook navigated Trump's administration with a direct, focused strategy.
Cook often bypassed lobbyists and government relations executives, opting instead for one-on-one meetings and phone calls with Trump.
He would focus on singular, data-driven points in discussions to influence policy in Apple's favor.
This approach reportedly helped Apple avoid some of the harsher impacts of Trump's trade tariffs in 2019 and positioned the company to benefit from the administration's 2017 tax reforms.
See Also: <a href="https://www.benzinga.com/news/treasuries/24/11/42157400/economist-peter-schiff-criticizes-trumps-treasury-pick-scott-bessent-says-he-will-have-to-find-buyers-for-trillions-in-new-debt-each-year-his-job-is-to-continue-the-ponzi">Economist Peter Schiff Criticizes Trump&#8217;s Treasury Pick, Scott Bessent, Says He Will Have To Find Buyers For Trillions In New Debt Each Year</a>
Cook also strategically aligned Apple's interests with Trump's agenda, ensuring mutual benefits. For instance, he didn't refute Trump's claim of credit for an Austin manufacturing plant that was neither new nor owned by Apple.
The report noted that doing so allowed Trump to appear successful while maintaining Apple's goodwill.
Leaders of other major companies, including Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) CEO Sundar Pichai and Meta Platforms, Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) Mark Zuckerberg are reportedly employing similar strategies.
According to the report, executives from Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) and FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) have also attempted direct communication with Trump.
Meanwhile, some have reportedly explored leveraging connections through the Department of Government Efficiency (DOGE), a role Trump assigned to Elon Musk after the Tesla Inc. CEO&#8217;s <a href="https://www.benzinga.com/news/24/11/42157649/trumps-doge-co-lead-elon-musk-slams-lockheed-martins-f-35-fighter-jets-advocates-drone-warfare-as-pentagon-defends-1-8-trillion-program">vocal support for his campaign</a>.
Why It Matters: Trump previously said that <a href="https://www.benzinga.com/markets/equities/24/10/41351251/trump-says-google-has-a-lot-of-power-but-stops-short-of-endorsing-a-break-up">Pichai updated him</a> on trending Google searches and Zuckerberg praised his <a href="https://www.benzinga.com/news/24/09/40785288/did-mark-zuckerberg-really-say-no-way-i-can-vote-for-a-democrat-in-this-election-to-trump">response to an assassination attempt</a>, showing their efforts to establish rapport.
Since Trump&#8217;s victory in the 2024 U.S. Presidential election, both the stock market and the cryptocurrency sector have experienced significant growth.
The S&amp;P 500 has increased by 3.22%, rising from 5,782 on Nov. 5 to 5,969 as of Friday&#8217;s close. The SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) which tracks the S&amp;P 500 Index has had a similar momentum since Trump&#8217;s victory, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
During the same period, NASDAQ has risen 2.71% to reach 20,776.23. The Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) which tracks the performance of the Nasdaq-100 Index gained 2.75%.
On the other hand, the overall market cap of the cryptocurrency sector has risen to $3.37 trillion, up 44.63% from $2.33 trillion on Nov. 5.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/42137295/as-mstrs-michael-saylor-says-warren-buffett-is-destroying-berkshire-capital-analyst-suggests-overpricedhot-stock-market-could-be-the-reason-oracle-of-omaha-is-sitting-on-325b-cash" target="_blank" rel="noreferrer noopener">As MSTR's Michael Saylor Says Warren Buffett Is ‘Destroying' Berkshire Capital, Analyst Suggests ‘Overpriced…Hot Stock Market' Could Be The Reason Oracle Of Omaha Is Sitting On $325B Cash</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photos courtesy: Wikimedia and WEF on Flickr

Politics

Tech

Media

AAPL

GOOG

GOOGL

How Tim Cook's Strategy To Win Over Trump Gave Apple A Competitive Edge, And Why Sundar Pichai, Mark Zuckerberg And Others Might Be Following His Playbook

Needham analyst Mike Cikos maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and raises the price target from $1075 to $1150.

Needham Maintains Buy on ServiceNow, Raises Price Target to $1150

Howard Lutnick, chief executive officer of Cantor Fitzgerald &#8211; which has about $3.53 billion in holdings &#8211; has been named as the co-chair of President-elect Donald Trump&#8216;s transition team. Lutnick will lead the U.S. Department of Commerce.
Top Holdings Of Lutnick&#8217;s Firm: According <a href="https://www.sec.gov/Archives/edgar/data/1024896/000092963824003880/0000929638-24-003880-index.html">to</a> Cantor Fitzgerald&#8217;s third-quarter 13F filings, top holdings of the firm include SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), GCM Grosvenor Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCMG#NASDAQ">GCMG</a>), and Rumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>).
In the September quarter, Lutnick&#8217;s financial services firm purchased about 1.17 million shares of Tesla with 1.74 million put options in Q3. It bumped up its call options by 4,967% to 152,000 shares from the <a href="https://13f.info/13f/000092963824003880/compare/000092963824002803">quarter-ended in July</a>. The total value of the fund&#8217;s exposure to Tesla stood at $804 million in Q3.
Cantor Fitzgerald also increased its position in Nvidia by 7,015%, <a href="https://13f.info/13f/000092963824003880/compare/000092963824002803">compared to the second quarter</a>, with a total holding of 3.56 million shares in Q3. It increased Nvidia puts in Q3 by 1,268% to 5.46 million shares and Nvidia call options by 3,213% to 778,600 shares. The total exposure to Nvidia in value terms stood at $1.192 billion.
The fund had 1.23 million of put options and 600,000 call options on SPDR S&amp;P 500 ETF TR representing a total value of $1.05 billion in Q3. GCM Grosvenor and Rumble reflected 2.1% and 1.2% of the fund&#8217;s total holdings, valued at $73.03 million and $42.04 million, respectively.
See Also: <a href="https://www.benzinga.com/news/treasuries/24/11/42157400/economist-peter-schiff-criticizes-trumps-treasury-pick-scott-bessent-says-he-will-have-to-find-buyers-for-trillions-in-new-debt-each-year-his-job-is-to-continue-the-ponzi">Economist Peter Schiff Criticizes Trump&#8217;s Treasury Pick, Scott Bessent, Says He Will Have To Find Buyers For Trillions In New Debt Each Year</a>
Why It Matters: Lutnick was also considered as a top pick for the Secretary of Treasury along with Scott Bessent. Tesla CEO and Trump&#8217;s Department of Government Efficiency (DOGE) co-lead Elon Musk <a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">rallied for Lutnick</a> in a post on his social media platform, X, calling on others to weigh in on the appointment.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Would be interesting to hear more people weigh in on this for <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a> to consider feedback. My view fwiw is that Bessent is a business-as-usual choice, whereas <a href="https://twitter.com/howardlutnick?ref_src=twsrc%5Etfw">@howardlutnick</a> will actually enact change. Business-as-usual is driving America bankrupt, so we need change… <a href="https://t.co/igGLZOJ8wz">https://t.co/igGLZOJ8wz</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1857819784865362211?ref_src=twsrc%5Etfw">November 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
However, Bessent was appointed the Treasury Secretary. According to <a href="https://www.benzinga.com/government/regulations/24/11/41909846/trumps-treasury-pick-frontrunner-scott-bessent-could-shift-wall-street-crypto" target="_blank" rel="noreferrer noopener">betting markets</a>, Bessent was a frontrunner with an 82% probability of securing the nomination.
The third-quarter 13F filing from Bessent's Key Square Group fund shows that they have liquidated all their holding in the September quarter.
In the <a href="https://13f.info/13f/000117266124003417-key-square-capital-management-llc-q2-2024" target="_blank" rel="noreferrer noopener">second quarter</a>, the fund had a highly concentrated portfolio, with equal investments in two banking-focused ETFs: the SPDR S&amp;P Regional Banking ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>) and the SPDR S&amp;P Bank ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBE#NYSE">KBE</a>), each making up 50% of the fund.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/42150794/trump-picks-hedge-fund-exec-scott-bessent-as-treasury-secretary-what-president-elects-choice-means-for-americas-economic-future" target="_blank" rel="noreferrer noopener">Trump Picks Hedge Fund Exec Scott Bessent As Treasury Secretary: What President-Elect's Choice Means For America's Economic Future</a></li>
</ul>
Photo courtesy: Cantor Fitzgerald

GCMG

NVDA

TSLA

Trump's Commerce Secretary Pick Howard Lutnick's Fund Owns $1.19B In Nvidia, $804M In Tesla: Here Is A Look At His Portfolio

Donald Trump&#8216;s Treasury Secretary pick Scott Bessent&nbsp;envisions a significant &#8220;global economic reordering&#8221; and aims to play a role in this transformation.
What Happened:&nbsp;In his first interview since Trump made the announcement, Bessent outlined his policy priorities, focusing on fulfilling tax-cut promises made by&nbsp;Trump. These include making first-term tax reductions permanent and removing&nbsp;taxes on tips, social security benefits, and overtime pay, The Wall Street Journal <a href="https://www.wsj.com/economy/scott-bessent-sees-a-coming-global-economic-reordering-he-wants-to-be-part-of-it-533d6e71">reported</a>&nbsp;on Monday.
Additionally, Bessent, who will be replacing Janet Yellen after Trump&#8217;s induction, plans to implement tariffs and reduce government spending. He emphasized the importance of &#8220;maintaining&nbsp;the status of the dollar&nbsp;as the world's reserve currency.&#8221;
Bessent told WSJ that he believes the president-elect&#8217;s strategy&nbsp;to extend tax cuts and&nbsp;deregulate parts of the U.S.&nbsp;economy could lead to an &#8220;economic lollapalooza.&#8221;
He expressed his desire to contribute to this anticipated economic shift, stating, &#8220;We&nbsp;are going to have to&nbsp;have some kind of a&nbsp;grand global economic reordering.&#8221; Bessent argues he has studied these dynamics and is eager to be involved in shaping the future economic landscape.
See Also:&nbsp;<a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Appears &#8216;Frustrated&#8217; As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List</a>
Why It Matters: The appointment of&nbsp;Bessent&nbsp;as U.S. Treasury Secretary by the President-elect&nbsp;is a strategic move that has drawn significant attention. Bessent, founder of Key Square Group, was <a href="https://www.benzinga.com/government/regulations/24/11/42150805/trump-picks-hedge-fund-exec-scott-bessent-as-treasury-secretary-what-president-elects-choice-means-for-americas-economic-future">selected over other notable candidates l</a>ike former Fed Governor Kevin Warsh and private equity executive Marc Rowan. Trump praised Bessent as a leading international investor and strategist.
However, not everyone is optimistic about this choice. Economist&nbsp;Peter Schiff&nbsp;<a href="https://www.benzinga.com/news/treasuries/24/11/42157400/economist-peter-schiff-criticizes-trumps-treasury-pick-scott-bessent-says-he-will-have-to-find-buyers-for-trillions-in-new-debt-each-year-his-job-is-to-continue-the-ponzi">criticized the decision,</a> suggesting that Bessent&#8217;s role would involve managing substantial national debt. Schiff humorously referred to him as the &#8220;Secretary of the Debt&#8221; on social media, highlighting concerns about the financial implications of Trump&#8217;s tax cut promises. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42154568/georgia-election-workers-demand-giuliani-be-held-in-civil-contempt?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Georgia Election Workers Demand Giuliani Be Held In Civil Contempt</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Government

Economics

Trump's Treasury Secretary Pick Scott Bessent Says A 'Global Economic Reordering' Is On The Way, Argues President-Elect's Policies Will Lead To An 'Economic Lollapalooza'

A whale investor offloaded millions worth of Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>) as the frog-themed cryptocurrency corrected sharply over the weekend.
What Happened: On-chain tracking platform&nbsp;Spot on Chain&nbsp;reported a massive sale of PEPE by a trader with huge cryptocurrency holdings. 
The trader, dubbed &#8220;super whale,&#8221; sold 74.07 billion PEPE, equivalent to $1.53 million, for 448.1 Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) on Sunday. In the last three days, they liquidated a total of 130.2 billion PEPE, amounting to $2.71 million, for 891 Ether.
Despite the massive sale, the whale still holds a staggering 3.241 trillion PEPE, valued at $64.1 million, with a profit of $68.3 million, marking a 12.6X return on investment.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This super <a href="https://twitter.com/search?q=%24PEPE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$PEPE</a> whale sold 74.07B <a href="https://twitter.com/search?q=%24PEPE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$PEPE</a> ($1.53M) for 448.1 <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> today as the price dropped. Over the last 3 days, the whale sold 130.2B <a href="https://twitter.com/search?q=%24PEPE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$PEPE</a> ($2.71M) for 891 <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a>, leaving 3.241T <a href="https://twitter.com/search?q=%24PEPE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$PEPE</a> ($64.1M) with a $68.3M profit (12.6x). Meanwhile, this whale's still buying <a href="https://twitter.com/search?q=%24EIGEN&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$EIGEN</a>,… <a href="https://t.co/itSX3FjLq1">https://t.co/itSX3FjLq1</a> <a href="https://t.co/vN8p32FNvH">pic.twitter.com/vN8p32FNvH</a>
&mdash; Spot On Chain (@spotonchain) <a href="https://twitter.com/spotonchain/status/1860877829065572676?ref_src=twsrc%5Etfw">November 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/24/11/42156858/dogecoin-foundation-pushes-back-against-tumps-speculated-crypto-tax-policy-favoring-us-companies">Dogecoin Foundation Shares Message Against Trump&#8217;s Tax Favoritism For US Crypto Firms</a>
Why It Matters: The sale comes amid a price drop in the third-largest meme coin by market capitalization. PEPE retraced as much as 7.7% since Saturday morning and 8.39% over the week. 
Large transactions by &#8216;whales&#8217; or wealthy traders can significantly impact the market, influencing retail to follow suit and causing price swings.
Interestingly, large transaction volume plunged by more than 50% in the last 24 hours, <a href="https://app.intotheblock.com/?end_offset=20">according </a>to IntoTheBlock. Moreover, the balances of long-term PEPE holders increased marginally by 0.3%.
The observations from the aforementioned indicators suggested a probable shift in trading strategy from selling to HODLing.
Price Action: At the time of writing, PEPE was trading at $0.00002038, up marginally by 0.80% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/11/42157756/firm-led-by-trumps-commerce-secretary-pick-howard-lutnick-reportedly-in-talks-for-a-multi-billion-dollar-bitcoin-lending-project-with-tether">Trump&#8217;s Commerce Secretary Pick Howard Lutnick-Led Firm In Talks For A Bitcoin Lending Project With Tether: Report</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

$PEPE

Influential Whale Cashes Out $2.7M Worth Of PEPE As Frog-Themed Crypto Takes U-Turn

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) with a Hold.

Reiteration

LXRX

Needham Reiterates Hold on Lexicon Pharmaceuticals

Needham analyst Quinn Bolton reiterates Cerence (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>) with a Hold.

CRNC

Needham Reiterates Hold on Cerence

Sportradar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) today announced the launch of generative AI (gen AI) audio, a new feature within its ad:s multi-channel marketing service. The tool leverages the power of gen AI integrated with Sportradar's live data, to automate the creation of personalized, real-time audio adverts for sportsbook and casino operators across one of the fastest growing digital marketing channels globally.
Ad:s gen AI audio provides operators with a ready-to-use audio marketing solution, allowing them to generate creative content during key sporting and gaming moments to efficiently scale advertising efforts into podcast streaming services and internet radio networks. Sportradar's industry-leading technology automatically creates customised and dynamic adverts – featuring live-data to update odds, jackpots, and upcoming events— to increase brand awareness, uplift purchase intent and increase the likelihood of customer acquisition.
AI-generated audio adverts are the latest addition to Sportradar's comprehensive, industry-leading, end-to-end marketing services, driving brand awareness, acquisition and retention across channels including programmatic display, video, audio, digital-out-of-home (DOOH), paid social media, paid search, sponsorships and affiliate marketing.
Niki Beier, SVP Marketing Services, said: "Sports fans and bettors are increasingly consuming audio content, with listenership increasing by over 1000% in the past seven years1. To deliver maximum marketing efficiency, we're providing a sophisticated yet simple-to-use solution to sportsbook and casino operators. Through our gen AI technology, we're making it easy for clients to integrate audio adverts into their acquisition and branding campaigns, to reach more customers with real-time relevant audio messages, without the need for creative teams or a high production budget."

SRAD

Sportradar Launches Gen AI Audio Ads for Real-Time Sportsbook Marketing

Earnings

NIPG

NIP Group Reported H1 Revenue Of $39.34M Vs $38.56M YoY, EPS Loss Of $(1.04) Vs $(0.71) YoY

Macro Economic Events

Econ #s

Germany Ifo Business Climate Index For November 85.7 Vs. 86.1 Est.; 86.5 Prior

Germany Current Assessment For November 84.3 Vs. 85.4 Est.; 85.7 Prior

Germany Business Expectations For November 87.2 Vs. 87.0 Est.; 87.3 Prior

VivoPower International PLC (Nasdaq: "VVPR") (the "Company" or "VivoPower") is on track to file its Annual Report on Form 20-F for the fiscal year ending June 30, 2024, no later than November 29, 2024, in compliance with NASDAQ's filing requirements.
The delay in filing the Form 20-F has been primarily due to significant strategic changes, including the sale of the Aevitas critical power businesses, the business combination agreement involving Tembo e-LV B.V. and Cactus Acquisition Corp. 1 Ltd., and other previously announced updates. Additionally, the Company's management and auditors have been focussed on completing the audited accounts for Tembo e-LV B.V. ("Tembo"), a subsidiary of VivoPower, which are required to be included in the Registration Statement on Form F-4 to be filed in connection with Tembo's business combination with Cactus Acquisition Corp. 1 Ltd.
VivoPower anticipates filing the Form 20-F no later than November 29, 2024.
Upon filing the Form 20-F Annual Report, the Company will be able to proceed with its annual shareholder update call. Details of the call will be provided separately and will be available on the Company's website. VivoPower aims to release this information before Friday, December 6, 2024.

Regulations

VVPR

VivoPower Targets November 29 for Form 20-F Filing Amid Strategic Changes and Tembo Business Updates, Prepares for Shareholder Update Call in December

Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions.
An analysis of data from more than 9,000 propensity-matched patients in the STS/ACC TVT Registry1 demonstrated that those who received Edwards' newest generation SAPIEN 3 Ultra RESILIA valve experienced outstanding one-year outcomes that continuously surpassed recipients of the earlier generation SAPIEN 3 and SAPIEN 3 Ultra valves. Patients receiving the SAPIEN 3 Ultra RESILIA valve experienced extremely low mortality, low rates of reintervention, larger effective orifice areas, lower echo-derived gradients across all valve sizes and no paravalvular leak in 84.4% of cases.
"These strong, real-world data continue to demonstrate that patients treated with a SAPIEN valve experience excellent outcomes with rapid recovery and improved quality of life," said Larry Wood, Edwards' corporate vice president and group president, transcatheter aortic valve replacement and surgical structural heart. "These data add to the immense body of evidence with multiple years of follow up on the Edwards SAPIEN valve platform and more than 10 years of clinical experience with the RESILIA tissue."
Patients in the SAPIEN 3 Ultra RESILIA valve cohort, who had an average STS score of 3.6 and average age of 77, experienced meaningful quality of life benefits with a clinically significant average 31-point increase in KCCQ2 score and one-day length of hospital stay with 93% discharged to their homes.
"This is the first large-population study that showed the latest generation SAPIEN 3 Ultra RESILIA valve results in improved 1-year survival after TAVR versus prior generation valves, given it reduces mild or greater paravalvular leak," said Gilbert Tang, MD, MSc, MBA, Surgical and Academic Director of the Structural Heart Program for the Mount Sinai Health System and Professor and Vice-Chair of Innovation in Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai. "This finding particularly affected low surgical risk patients, where the impact would matter more because of their longer life expectancies."
Dr. Tang is a consultant for Edwards Lifesciences. 1 The STS/ACC TVT Registry is a collaboration between the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC). 2 The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item survey that measures the impact of heart failure on a patient's quality of life, symptoms, and physical function.

Edwards Lifesciences' SAPIEN 3 Ultra RESILIA Valve Shows One-Year Outcomes: Data Presented at PCR London Valves

Highlights for the Quarter Ended September 30, 2024
<ul>
<li>Transaction volume was 7,046 units for the three months ended September 30, 2024, an increase of 25.7% from 5,605 units in the last quarter and an increase of 81.4% from 3,884 units in the same period last year.</li>
<li>Retail transaction volume was 6,005 units, an increase of 46.8% from 4,090&nbsp;units in the last quarter and an increase of 162.6% from 2,287 units in the same period last year.</li>
</ul>

Uxin Limited Reported Q2 Transaction Volume Of 7,046 Units, Up 81.4% YoY, Retail Transaction Volume Of 6,005 Units, Up By 162.6% YoY

Guardion Health Sciences reports Q1 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Guardion Health Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ghsi-stock-quote/">GHSI</a>) just reported results for the first quarter of 2024.<ul><li>Guardion Health Sciences reported earnings per share of -$3.71. This was below the analyst estimate for EPS of -88 cents.</li><li>The company reported revenue of $3.00 million.</li><li>This was 3.86% worse than the analyst estimate for revenue of $3.12 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/ghsi-stock-earnings-guardion-health-sciences-for-q1-of-2024/">GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024

Tandem Diabetes Care, Guardion Health, GT Biopharma among healthcare movers

Guardion Health Sciences (GHSI) has issued an announcement. Guardion Health Sciences, Inc. has mutually agreed with Craig Sheehan, its Chief Commer...

Guardion Health Sciences CCO Sheehan Exits with Compensation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Guardion Health Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ghsi-stock-quote/">GHSI</a>) just reported results for the second quarter of 2024.<ul><li>Guardion Health Sciences reported earnings per share of -$1.64. This was below the analyst estimate for EPS of -66 cents.</li><li>The company reported revenue of $72,918.</li><li>This was 97.73% worse than the analyst estimate for revenue of $3.21 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ghsi-stock-earnings-guardion-health-sciences-for-q2-of-2024/">GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q2 2024

Guardion Health Sciences reports Q2 results

Guardion Health Sciences declares $5.00 dividend

Guardion Health Sciences ( ($GHSI) ) has shared an announcement. Guardion Health Sciences, Inc. has announced the departure of its President and CE...

Guardion Health Sciences CEO Jan Hall Set to Depart

Guardion Health Sciences announces adoption of plan of dissolution and liquidation

Guardion Health Sciences ( ($GHSI) ) has issued an announcement. Guardion Health Sciences, Inc. has initiated a significant corporate shakeup, anno...

Guardion Health Sciences Announces Delisting and New Interim CEO

AONC

BDRX

GHSI

GTBP

LSDI

MYMD

SABS

TNDM

XYLO

Small Cap

Opinion

Press Releases

Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Guardion Health Sciences Announces

Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company's Special Meeting of Stockholders to be held on May 23, 2024

Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution

Comments

Guardion Health Sciences

Vendite allo scoperto

Guardion Health Sciences (OTC:GHSI) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO